EUVIMEDEUVIMED entdecken
Fallbericht

Successful Management of Febrile Infection–Related Epilepsy Syndrome Using Cytokine-Directed Therapy

Dana B Harrar iD, Ilyse Genser, Mejdi Najjar, Emily Davies, Sangeeta Sule, Birte Wistinghausen, Raphaela Goldbach-Mansky, Elizabeth Wells

Journal of Child Neurology · 2024-10 · 39 (11-12) · 440-445

DOI: 10.1177/08830738241273448 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Journal of Child Neurology, online erschienen am 28.08.2024. Verfasst von Dana B Harrar und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Neurology, Children's National Hospital, Washington, DC, USA. Hauptthemen laut MEDLINE: Cytokines. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 18 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Here we describe a pediatric patient with febrile infection–related epilepsy syndrome with a good functional and neurologic outcome after treatment with early and aggressive cytokine-directed immunomodulatory therapy and a seizure management strategy that intentionally avoided a barbiturate coma. A 5-year-old previously healthy male presented with staring, behavioral arrest, and encephalopathy evolving to super-refractory status epilepticus. He had had onset of fever 5 days prior. He was treated with early and aggressive immunomodulatory therapy targeted to his evolving cytokine profile. He was also treated with the ketogenic diet, antiseizure medications, and continuous anesthetic infusions. Pentobarbital was purposely avoided. Now, 2½ years later, he attends mainstream school, has attention-deficit hyperactivity disorder (ADHD), mild neurocognitive impairment, and well-controlled epilepsy. By using cytokine-directed immunotherapy and avoiding a barbiturate coma, we were able to successfully treat a pediatric patient with febrile infection-related epilepsy syndrome and achieve a good outcome.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CytokinesHumansMaleChild, PreschoolStatus EpilepticusEpileptic Syndromes

Stichwörter der Autor:innen

cytokinesfebrile infection-related epilepsy syndromeimmunotherapyketaminepentobarbital

Substanzen

Cytokines

Autor:innen und Institutionen

  • Division of Neurology, Children's National Hospital, Washington, DC, USA.
  • Division of Critical Care Medicine, Children's National Hospital, Washington, DC, USA.
  • Division of Rheumatology, Children's National Hospital, Washington, DC, USA.
  • Division of Oncology, Children's National Hospital, Washington, DC, USA.
  • Center for Cancer and Blood Disorders, Children's National Hospital, Washington, DC, USA.
  • Center for Cancer and Immunology Research, Children's National Research Institute, Children's National Hospital, Washington, DC, USA.

ORCID-Profile: Dana B Harrar

Zitieren

APA

Harrar, D. B., Genser, I., Najjar, M., Davies, E., Sule, S., Wistinghausen, B., Goldbach-Mansky, R., & Wells, E. (2024). Successful Management of Febrile Infection–Related Epilepsy Syndrome Using Cytokine-Directed Therapy. Journal of Child Neurology, 39(11-12), 440-445. https://doi.org/10.1177/08830738241273448

Vancouver

Harrar DB, Genser I, Najjar M, Davies E, Sule S, Wistinghausen B, et al. Successful Management of Febrile Infection–Related Epilepsy Syndrome Using Cytokine-Directed Therapy. Journal of Child Neurology. 2024;39(11-12):440-445. doi:10.1177/08830738241273448

BibTeX
@article{Harrar2024,
  author = {Harrar, Dana B and Genser, Ilyse and Najjar, Mejdi and Davies, Emily and Sule, Sangeeta and Wistinghausen, Birte and Goldbach-Mansky, Raphaela and Wells, Elizabeth},
  title = {Successful Management of Febrile Infection–Related Epilepsy Syndrome Using Cytokine-Directed Therapy},
  journal = {Journal of Child Neurology},
  year = {2024},
  volume = {39},
  number = {11-12},
  pages = {440--445},
  doi = {10.1177/08830738241273448}
}
Kostenlos starten →